Navigation Links
Hepatitis C therapy: Inhibiting newly discovered microDNA molecule

Last fall Dr. Peter Sarnow and a team of Stanford University scientists reported that the hepatitis C virus needs a specific microRNA, named miR-122, in order to replicate in cultured liver cells.

When the scientists inactivated the microRNA, the amount of hepatitis C virus RNA was reduced by approximately 80 percent. The discovery was widely heralded for its potential to develop new antiviral agents against hepatitis C, the most common blood-borne viral infection in the United States, affecting more than 2.5 million Americans and a staggering 170 million people worldwide. The best treatment regimens now available are difficult, expensive, laden with serious side effects and effective in only half the cases.

Dr. Sarnow discusses the most recent findings in this work on April 5 at Experimental Biology 2006 in San Francisco. His presentation is part of the scientific program of the American Society for Biochemistry and Molecular Biology.

MicroRNAs, or miRNAs for short, are small RNA molecules that regulate genes in many plant and animal species. Although miRNAs were not discovered until the mid-1990, a growing number of studies suggest that over 300 human genes encode microRNAs and that these microRNAs may control gene expression for as much as a third of the human genome, acting as key regulators of processes as diverse as early development, cell proliferation and cell death, and cell differentiation. Some miRNAs are located throughout the body, while others are found only in specific tissue. The miRNA whose surprising new role was discovered by Dr. Sarnow and his colleagues is located only in the liver. The Sarnow team found that miR-122 binds to a specific noncoding binding region in virus, called target 5' NCR. This is the first example of an animal RNA that interacts with its target 5' NCR, and opens an interesting possibility that other viral 5' NCRs are similarly targeted by different miRNAs.


'"/>

Source:Federation of American Societies for Experimental Biology


Page: 1

Related biology news :

1. Scientists Replicate Hepatitis C Virus in Laboratory
2. Norovirus, AIDS vaccine and Hepatitis Virus
3. UCLA study assesses cost-effectiveness of Hepatitis B drugs
4. Natural Killers Could Lead to New Hepatitis Treatments
5. FDA Approves New Treatment for Chronic Hepatitis B
6. Identification of specific genes predicts which patients will respond to Hepatitis C treatment
7. Hepatitis C responds best to combo of ribavirin and interferon, study concludes
8. Use of high hydrostatic pressure to inactivate Hepatitis A virus in oysters studied
9. Hepatitis C complicated by morphine withdrawal
10. Hepatitis B accounts for 40 percent of missing Asian women
11. Hepatitis E takes a piggyback
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2018)... ... 10, 2018 , ... For the first time, an app ... about their treatment options. The unique patient education tool seeks to improve survival ... was developed through a collaboration between the Centers for Disease Control and ...
(Date:10/5/2018)... Utah and BOSTON (PRWEB) , ... October 04, ... ... in delivering cloud-based enterprise-class unified communications and collaboration solutions, was present at Microsoft ... support of Office 365 communication solutions. , Microsoft issued a statement about the ...
(Date:10/3/2018)... ... 03, 2018 , ... Fit4D, a leading diabetes management technology-enabled ... Jimmy Lee, as Strategic Advisor to the company’s board. Mr. Lee is a ... a Senior Executive at Anthem, he had P&L accountability for $35 billion of ...
Breaking Biology News(10 mins):
(Date:9/27/2018)... ... September 26, 2018 , ... NDA Partners Chairman ... senior quality, regulatory, and in vitro diagnostic device expert with more than 28 ... joined the firm as an Expert Consultant. Her experience includes leadership roles in ...
(Date:9/27/2018)... BUDAPEST, Hungary and CAMBRIDGE, Mass. (PRWEB) , ... ... ... headquartered in Budapest with US offices in Cambridge, MA, announce today that Holotype ... customers or collaborators at the annual meeting of the American Society for Histocompatibility ...
(Date:9/15/2018)... ... ... Next-generation genomic sequencing is transforming what is known about pediatric cancer and ... the sheer size of genomics data has made sharing across the global scientific community ... advance cures by reducing the technological barriers to data sharing and analysis. Developed by ...
(Date:9/12/2018)... ... September 11, 2018 , ... Sterlitech Corporation, a global leader ... membranes from Fluid Technology Solutions (FTS H2O) to their offering of filtration products. ... cellulose triacetate (CTA) material. The highly hydrophilic nature of the CTA FO membranes ...
Breaking Biology Technology: